Supply Chain/Technology

Latest Issue of OR Manager
July 2018
Home Supply Chain/Technology

Effectiveness of reprocessing reusable flexible bronchoscopes

Editor's Note In a study on the effectiveness of reprocessing flexible bronchoscopes presented June 14 by Ofstead and Associates at the Association for Professionals in Infection Control’s annual conference in Minneapolis, the majority of bronchoscopes were found to be contaminated and damaged even when cleaned and high-level disinfected according to…

Read More

By: Judy Mathias
June 20, 2018
Share

FDA letter updates risks of Type III endoleaks with aortic endovascular graft systems

Editor's Note In a June 19 letter to healthcare providers, the Food & Drug Administration (FDA) says it continues to evaluate information from several sources, including manufacturers, on the risks associated with Type III endoleaks with various endovascular graft systems used for treatment of abdominal aortic aneurysms (AAAs) and aorto-iliac…

Read More

By: Judy Mathias
June 20, 2018
Share

Cybersecurity should be high on healthcare priority lists

No homeowners willingly allow a burglar to enter their home and steal their most valuable possessions. Instead, people put locks on doors, install alarm systems, build fences, or keep big dogs. The thieves may still get in, but deterrents like these will reduce the risk of a successful burglary. Ambulatory…

Read More

By: Janet M. Boivin, BSN, BSJ, RN
June 20, 2018
Share

Machine-learning algorithm predicts hypotension during surgery

Editor's Note In this study, researchers at UCLA Medical Center in Los Angeles applied machine learning to arterial pressure waveforms to develop an algorithm that predicted intraoperative hypotension 15 minutes before it occurred in 84% of cases. Two sets of data were used to build the algorithm. One set consisted…

Read More

By: Judy Mathias
June 12, 2018
Share

FDA: Hospira recalls two lots of Naloxone Hydrochloride Injection

Editor's Note The Food & Drug Administration on June 4 announced the recall by Hospira, Inc, of two lots of its opioid antagonist Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). The two lots, 72680LL and 76510LL, were recalled because…

Read More

By: Judy Mathias
June 11, 2018
Share

You may also be interested in these sessions at the OR Manager Conference this September in Nashville, TN

Determining if an Orthopedic Robotic Program Is Right for Your Surgical Suite

Event Session
Share

FDA issues Class I Recall of CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope

Editor's Note The Food & Drug Administration on June 6 identified the recall by Maquet Datascope Corp of its CARDIOSAVE Hybrid Intra-aortic Balloon Pump as Class I, the most serious. The recall was initiated because of a design issue that allows fluid to seep into the device, which can lead…

Read More

By: Judy Mathias
June 7, 2018
Share

Study: Medical device tax hurts investment in R&D

Editor's Note: This study from Iowa State University shows companies have cut funding for research and development (R&D) in response to the medical device tax imposed by the Affordable Care Act. Since 2013, the 2.3% excise tax has significantly reduced: R&D investment by $34 million Sales revenue by $188 million…

Read More

By: Judy Mathias
June 6, 2018
Share

FDA: New labeling for liquid-filled intragastric balloons

Editor's Note The Food & Drug Administration on June 4 announced that it had approved new labeling on potential risks for liquid-filled intragastric balloons by Apollo Endosurgery and ReShape Lifesciences. The new labeling for the Orbera and ReShape balloon systems includes more information about possible deaths linked to the use…

Read More

By: Judy Mathias
June 6, 2018
Share

FDA: Recall of STAT-Check and Medline manual resuscitator bags

Editor's Note The Food & Drug Administration on June 1 announced the recall by SunMed Holdings of 18,808 units of its STAT-Check and Medline manual resuscitator bags. The recall was initiated because the patient port retaining ring of the bags may not fully seat, which could allow the patient port…

Read More

By: Judy Mathias
June 5, 2018
Share

FDA: Class I recall of HeartWare HVAD system by Medtronic

Editor's Note The Food & Drug Administration on June 1 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system as Class I, the most serious. The recall was initiated because of the possibility for an interruption to occur in the electrical connection between the system’s power…

Read More

By: Judy Mathias
June 4, 2018
Share
Upcoming Webinars
Live chat by BoldChat